VaxServe Thanks VNAA Members for Another Successful Influenza Season!
Tuesday, January 22, 2013
by: Membership and Corporate Relations Team

Section: Corporate Partners




We would like to thank the VNAA Members for purchasing Fluzone® Influenza Virus Vaccine from us this year. We remain committed in helping you provide your patients with Fluzone vaccine each flu season. While you are continuing to wrap up this current season we are starting to get ready and look at the 2013-2014 Fluzone Reservation Season. The reservation process will be underway soon and we would like to remind you why you have chosen Fluzone Vaccine as your influenza vaccine of choice and have chosen VaxServe as your distributor. 
 
Sanofi Pasteur and VaxServe remain the market leader through 2012-2013 influenza season:
        
  • Incomparable track record & experience
    • 40 years of experience producing Fluzone vaccine
    • Continually meets customer commitments with quantity requested and delivery times
  • Unrivaled capacity
    • Two US influenza vaccine manufacturing facilities
    • Capacity to manufacture up to 150 million total doses of trivalent inactivated vaccine
  • Unmatched portfolio
    • Indication starting at 6 months of age
    • Robust pipeline including quadrivalent and universal vaccines
    • Continued investigation of new technologies, innovative products, and manufacturing efficiencies
  • Specialty distributor that focuses on Vaccines
  • Relationship with Sanofi Pasteur, manufacturer of Fluzone vaccine  
  • Representatives are available to answer any questions about Fluzone vaccine 
 
Thank you again for another successful influenza season and we look forward to working with you throughout the 2013-2014 season.
 
VaxServe
Post a Comment

Name
Email
Comment